title: Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis.
authors.forename: Jason A
authors.initials: JA
authors.lastname: Roberts
authors.forename: Andrew A
authors.initials: AA
authors.lastname: Udy
authors.forename: Stephen
authors.initials: S
authors.lastname: O'Donoghue
authors.forename: Scott
authors.initials: S
authors.lastname: Briscoe
authors.forename: David L
authors.initials: DL
authors.lastname: Paterson
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Lipman
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002177:Candidiasis / Q000188:drug therapy / Q000382:microbiology; D016903:Drug Monitoring; D005260:Female; D005437:Flucytosine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006440:Hemofiltration; D006801:Humans; D007275:Injections, Intravenous; D008107:Liver Diseases / Q000188:drug therapy / Q000382:microbiology; D013158:Splenic Diseases / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000935:Antifungal Agents; D005437:Flucytosine